Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
EBioMedicine
.
2023 Dec:98:104853.
doi: 10.1016/j.ebiom.2023.104853.
Epub 2023 Oct 28.
Authors
Laura Ziegler
1
,
Verena Klemis
1
,
Tina Schmidt
1
,
Sophie Schneitler
2
,
Christina Baum
3
,
Jürgen Neumann
4
,
Sören L Becker
2
,
Barbara C Gärtner
2
,
Urban Sester
5
,
Martina Sester
6
Affiliations
1
Department of Transplant and Infection Immunology, Saarland University, Germany.
2
Department of Medical Microbiology and Hygiene, Saarland University, Germany.
3
Occupational Health Care Center, Saarland University, 66421, Homburg, Germany.
4
Department of Occupational Health, Robert Bosch GmbH, 66424, Homburg, Germany.
5
Department of Nephrology, SHG-Klinikum Völklingen, 66333, Völklingen, Germany.
6
Department of Transplant and Infection Immunology, Saarland University, Germany. Electronic address: martina.sester@uks.eu.
PMID:
38251468
PMCID:
PMC10628342
DOI:
10.1016/j.ebiom.2023.104853
No abstract available
Publication types
Letter
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Immunization, Secondary
Substances
COVID-19 Vaccines
Supplementary concepts
COVID-19 vaccine booster shot